Unternehmen Inovio Pharmaceuticals Inc Nyse
Aktien
INO
US45773H2013
INO
Biotechnologie
Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
DNA Medicines
100,0
%
| 10 | 100,0 % | 1 | 100,0 % | -91.89% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 1 | 100,0 % | -91.89% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25.03.19 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 01.06.02 |
Chief Tech/Sci/R&D Officer | - | 01.02.07 | |
Jeffrey Skolnik
CTO | Chief Tech/Sci/R&D Officer | - | 12.10.16 |
Michael Sumner
CTO | Chief Tech/Sci/R&D Officer | 59 | 27.06.22 |
Laurent Humeau
CTO | Chief Tech/Sci/R&D Officer | 57 | 18.02.14 |
Thomas Hong
IRC | Investor Relations Contact | - | - |
Cheryl Elder
LAW | General Counsel | - | - |
Shawn D. Bridy
PRN | Corporate Officer/Principal | - | 24.05.18 |
Maggie Campbell
AUD | Comptroller/Controller/Auditor | - | 01.03.06 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 01.12.03 |
Lota Zoth
BRD | Director/Board Member | 64 | 01.01.18 |
Jay Shepard
BRD | Director/Board Member | 66 | 15.01.20 |
Wendy Yarno
BRD | Director/Board Member | 68 | 06.12.17 |
David Weiner
FOU | Founder | 67 | 29.06.83 |
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25.03.19 |
Roger Dansey
BRD | Director/Board Member | 67 | 13.05.21 |
Ann Miller
BRD | Director/Board Member | 66 | 25.03.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 1 091 | 0 | 1 082 ( 99,18 %) | 98,40 % |
Aktie B | 1 | 25 910 701 | 25 498 234 ( 98,41 %) | 0 |
Unternehmenskontakt
Inovio Pharmaceuticals, Inc.
660 West Germantown Pike Suite 110
19462-1111, Plymouth Meeting
+267 440 4200
http://www.inovio.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+50.48% | 59.28 Mrd. | |
+41.42% | 40.94 Mrd. | |
-5.48% | 40.17 Mrd. | |
-5.16% | 28.69 Mrd. | |
+12.75% | 26.63 Mrd. | |
-20.41% | 18.89 Mrd. | |
+31.52% | 12.46 Mrd. | |
+0.23% | 12.42 Mrd. | |
+25.84% | 12.26 Mrd. |